Table 2.
Vital signs after acute (2-hour) and chronic (24-week) ingestion of BeneFlax or placebo.
| Outcome | Treatment | n | Baseline | 2-hour | 24-week | Range |
| Systolic blood pressure, mean (SD) | BeneFlax | 19 | 130 (24) | 136 (20) | 132 (14) | 100-178 |
| Placebo | 13 | 138 (10) | 134 (21) | 138 (21) | 99-167 | |
| Diastolic blood pressure, mean (SD) | BeneFlax | 19 | 79 (10) | 80 (9) | 79 (9) | 64-109 |
| Placebo | 13 | 77 (6) | 74 (5) | 76 (7) | 64-89 | |
| Respiratory rate, mean (SD) | BeneFlax | 19 | 16 (5) | 13 (3) | 13 (3) | 7.0-24 |
| Placebo | 13 | 15 (4) | 15 (4) | 14 (3) | 9.0-24 | |
| Heart rate, mean (SD) | BeneFlax | 19 | 63 (9) | 66 (7) | 69 (11) | 47-88 |
| Placebo | 13 | 64 (9) | 67 (7) | 63 (11) | 49-86 |